Here are relevant reports on : pet-care-market
-
Home Healthcare Market by Product (Therapeutic, Testing, Screening, Monitoring, Mobility Care), Service (Nursing, Infusion Therapy, Rehabilitation, Palliative Care), Indication (Cancer, Diabetes, CVD, Respiratory, Wound Care) - Global Forecast to 2030
The global home healthcare market, valued at US$285.3 billion in 2024, stood at US$309.9 billion in 2025 and is projected to advance at a resilient CAGR of 8.9% from 2025 to 2030, culminating in a forecasted valuation of US$473.8 billion by the end of the period. This growth is driven by the rising elderly population, which is more prone to chronic conditions such as hypertension, diabetes, and cardiovascular diseases, increasing the need for ongoing care at home.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Neonatal Care Equipment Market by Product (Neonatal Incubators, Convertible Warmers & Incubators, Respiratory Care Devices (Neonatal Ventilators), Monitoring Devices (Pulse Oximeters)), End User (General and Pediatric Hospitals) - Global Forecast to 2030
The global neonatal care equipment market, valued at US$2.0 billion in 2024, stood at US$2.2 billion in 2025 and is projected to advance at a resilient CAGR of 5.6% from 2025 to 2030, culminating in a forecasted valuation of US$2.8 billion by the end of the period. The neonatal care equipment market is driven by rising preterm birth rates, advancements in neonatal technology, and increasing government initiatives to reduce infant mortality.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Surfactants Market by Type (Anionic, Non-ionic, Cationic and Amphoteric), Application (Home Care, Personal Care, I&I Cleaners, Food & Beverage, Oilfield Chemicals, Agrochemicals, Textiles, Elastomers & Plastics), and Region - Global Forecast to 2031
The surfactants market size was USD 52.25 billion in 2026 and is projected to reach USD 66.95 billion by 2031, at a CAGR of 5.08% between 2026 and 2031. The key players include BASF SE (Germany), Stepan Company (US), Dow Inc. (US), Evonik Industries AG (Germany), Nouryon (Netherlands), Solvay S.A. (Belgium), Clariant AG (Switzerland), Indorama Ventures Public Company Limited (Thailand), Ashland Inc. (US), Kao Corporation (Japan), and Croda International Plc (UK).
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
European Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), End User (Hospital, Home care Setting) - Forecast to 2020
The European injectable drug delivery market is expected to reach $207.3 Billion by 2020 from $114.7 Billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements are driving the growth of this market. On the other hand, alternative delivery methods such as oral and transdermal, safety concerns, and blood-borne infections are hindering the growth of this market.
- Published: July 2015
- Price: $ 4950
- TOC Available:
-
Ventilators Market by Mobility (Intensive Care Ventilators, Transportable Ventilators), Type (Adult & Pediatric Ventilators), Interface (Invasive Ventilation), Mode (Combined Mode Ventilation), Care Setting (Hospitals & Clinics)- Global Forecast to 2031
The global ventilators market is projected to reach USD 3.10 billion by 2031, growing at a CAGR of 4.4% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Care Management Solutions Market by Component [Software (Integrated, Standalone)], Application (Chronic Care, Preventive, Utilization, Transitional), Deployment (On-prem, Cloud), End User (Hospital, ASC, Public & Private Payer) - Global Forecast to 2031
The global care management solution market is projected to reach USD 42.62 billion by 2031, growing at a CAGR of 13.6% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Nutricosmetics Market by Ingredient (Carotenoids, Vitamins, Omega 3 Fatty Acids, Others), Application (Personal Care, Health Care) & Region—Global Trends & Forecast to 2019
Nutricosmetics Market by Ingredient (Carotenoids, Vitamins, Omega 3 Fatty Acids, Others), Application (Personal Care, Health Care) & Region
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Essential Oils Market by Product Type, Application (Food & beverages, Cosmetics & Toiletries, Aromatherapy, Home Care, and Health Care), Source (Fruits & Vegetables, Herbs & Spices, Flowers), Method of Extraction and Region - Global Forecast to 2027
The global essential oils market size is projected to reach USD 15.3 billion by 2027, recording a CAGR of 11.8% during the forecast period. This report includes a study on the marketing and development strategies, along with the product portfolios of leading companies. It consists of profiles of leading companies, such as Cargill, Incorporated (US), DSM (Netherlands), Givaudan (Switzerland), International Flavors & Fragrances Inc. (US), Sensient Technologies Corporation (US), Symrise (Germany), Robertet SA (France), MANE (France), doTERRA (US), NOW Foods (US), Lebermuth, Inc. (US), BIOLANDES (France), Norex Flavours Private Limited (India) and India Essential Oils (India).
- Published: September 2022
- Price: $ 4950
- TOC Available:
-
Asia Pacific Pharmaceutical Drug Delivery Market by Route of Administration (Oral, Injectors (Auto Injectors), Implantable, Transmucosal, Nasal, Syringes), Application (Cancer, Diabetes), Care Setting (Hospital, Home Care) - Forecast to 2031
The Asia Pacific pharmaceutical drug delivery market, valued at US$457.9 million in 2025, stood at US$479.7 million in 2026 and is projected to advance at a resilient CAGR of 7.5% from 2026 to 2031, culminating in a forecasted valuation of US$687.9 million by the end of the period. The market growth for drug delivery in the APAC region is steadily expanding due to an increase in disease prevalence, an increase in the adoption rate of biologics, advancements in technologies, and an increase in regional production.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Patient Engagement Solutions Market by Component (Software (Pre-Care, Post-Care)) Therapy (CVD, Diabetes, Obesity, Fitness), Function (Telehealth, ePrescribing, Scheduling, Billing), Delivery, End User (Hospital, Payer, Patient) - Global Forecast to 2031
The global patient engagement solutions market is projected to reach USD 54.16 billion by 2031, growing at a CAGR of 12.2% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: January 2026
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
